联合腹水超滤浓缩回输术治疗肝硬化顽固性腹水的临床效果

The Clinical efficacy of Combined Ultrafiltration and Reinfusion of Ascites in Treatment of Liver Cirrhosis with Refractory Ascites

目的探讨常规治疗联合腹水超滤浓缩回输术在治疗肝硬化顽固性腹水中的效果。方法选取2013年4月至2014年5月收治的肝硬化顽固性腹水患者38例,随机分成试验组与对照组,各19例,对照组患者进行常规治疗,试验组患者在其基础上联合腹水超滤浓缩回输术治疗,比较两组患者的疗效及并发症。结果试验组患者总有效率为94.7%,对照组患者总有效率为63.2%,两组疗效比较差异有统计学意义(P<0.05);两组患者并发症比较差异无统计学意义(P>0.05)。结论常规治疗联合腹水超滤浓缩回输术的治疗用于肝硬化顽固性腹水患者,可明显改善患者存在的电解质紊乱,有效缓解肝硬化顽固性腹水。

Objective To conventional treatment combined with ascites reinfusion method in the treatment of intractable ascites due to cirrhosis of the effect.Methods 38 patients from 2013 April to 2014 May were intractable ascites of cirrhosis,were randomly divided into experimental group and control group,each 19 cases,the control group patients received routine treatment,patients in experimental group on the basis of combined ultrafiltration and reinfusion of ascites treatment,compared two groups of patients with curative effect and complications.Results In experiment group,the total efficiency of 94.7%,patients in the control group the total effective rate was 63.2%,there was significant difference between two groups（P〈0.05）;the curative effect of two groups of complications were not significant（P〈0.05）.Conclusion Conventional therapy combined with ascites reinfusion method for patients with refractory ascites of cirrhosis of the liver,can obviously improve the electrolyte disorders in patients with existing,more effectively relieve intractable ascites of cirrhosis.